Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
Donald E. Moss
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3438-3438
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 115
Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
Wang Liao, Jiaxin Xu, Bo Li, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 60
Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives
Natália Moreira, Jéssica Ellen Barbosa de Freitas Lima, Marcelo Fiori Marchiori, et al.
Journal of Alzheimer s Disease Reports (2022) Vol. 6, Iss. 1, pp. 177-193
Open Access | Times Cited: 59
Curcumin-Loaded Mesoporous Silica Nanoparticles Dispersed in Thermo-Responsive Hydrogel as Potential Alzheimer Disease Therapy
Taís de Cássia Ribeiro, Rafael Miguel Sábio, Marcela Tavares Luiz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1976-1976
Open Access | Times Cited: 53
Anthocyanins: Molecular Aspects on Their Neuroprotective Activity
César A. Zaa, Álvaro Marcelo, Zhiqiang An, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1598-1598
Open Access | Times Cited: 30
Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications
Niraj Kumar Jha, Niraj Kumar Jha, Mohana Vamsi Nuli, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102224-102224
Closed Access | Times Cited: 14
Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer’s Agents: Synthesis, Biological, and Molecular Docking Studies
Swati Pant, Ranjith Kumar K, Preeti Rana, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 783-797
Closed Access | Times Cited: 10
Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study
Bikram Saha, Agnidipta Das, Kailash Jangid, et al.
Current Research in Structural Biology (2024) Vol. 7, pp. 100124-100124
Open Access | Times Cited: 9
Symptoms and conventional treatments of Alzheimer's disease
Mehul R. Chorawala, Aayushi C. Shah, Aanshi J. Pandya, et al.
Elsevier eBooks (2024), pp. 213-234
Closed Access | Times Cited: 8
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons
Paola Sini, Thi Bang Chau Dang, Milena Fais, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8726-8726
Open Access | Times Cited: 55
Chemical and Bioinformatics Analyses of the Anti-Leishmanial and Anti-Oxidant Activities of Hemp Essential Oil
Luigi Menghini, Claudio Ferrante, Simone Carradori, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 272-272
Open Access | Times Cited: 36
Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)
Junyan Gao, Liping Li
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 13
Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer’s Disease
Violina T. Angelova, B. Georgiev, Tania Pencheva, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1194-1194
Open Access | Times Cited: 13
Therapeutic Potential of Human Stem Cell Implantation in Alzheimer’s Disease
Hau Jun Chan, Yanshree, Jaydeep Roy, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10151-10151
Open Access | Times Cited: 27
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy
Marialuigia Fantacuzzi, Rosa Amoroso, Simone Carradori, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114242-114242
Closed Access | Times Cited: 22
Evaluation of Antioxidative and Neuroprotective Activities of Total Flavonoids From Sea Buckthorn (Hippophae rhamnoides L.)
Zheng Wang, Wenqian Wang, Changlong Zhu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 19
Methoxyfuranocoumarins of Natural Origin–Updating Biological Activity Research and Searching for New Directions—A Review
Magdalena Bartnik
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 1, pp. 856-883
Open Access | Times Cited: 4
Specific Rosetta-based protein-peptide prediction protocol allows the design of novel cholinesterase inhibitor peptides
Iván Sanchis, Florencia Aimaretti, Matias Lupotti, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108202-108202
Closed Access
Mini meta-analysis of anticholinesterase actions of atorvastatin, simvastatin and rosuvastatin, and in silico identification of their protein targets in Mus musculus
F. K. Mohammad, Rawnaq Faris Al-Shalchi
Toxicology Reports (2025) Vol. 14, pp. 101958-101958
Closed Access
Integrating synthesis, enzyme inhibition and in silico studies: Carbamoyl luteolin derivatives targeting Alzheimer's disease
The‐Huan Tran, Nguyen Thi Ai Nhung, Thi‐Cam‐Nhung Cao, et al.
Journal of the Chinese Chemical Society (2025)
Closed Access
Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence
Marco Colizzi, Riccardo Bortoletto, Chiara Colli, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
Boswellic acids as promising agents for the management of brain diseases
Arezoo Rajabian, Mohammadreza Farzanehfar, Hossein Hosseini, et al.
Life Sciences (2022) Vol. 312, pp. 121196-121196
Closed Access | Times Cited: 17
Efficient Combination of Complex Chromatography, Molecular Docking and Enzyme Kinetics for Exploration of Acetylcholinesterase Inhibitors from Poria cocos
Tong Wu, Wanchao Hou, Chunming Liu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1228-1228
Open Access | Times Cited: 10
Static Binding and Dynamic Transporting‐Based Design of Specific Ring‐Chain‐Ring Acetylcholinesterase Inhibitor: From Galantamine to Natural Product
Zhiyang Zhang, Jianwu Lv, Yu Wang, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 25
Closed Access | Times Cited: 10
Labdanum Resin from Cistus ladanifer L. as a Source of Compounds with Anti-Diabetic, Neuroprotective and Anti-Proliferative Activity
David F. Frazão, Carlos Martins‐Gomes, T. Sosa, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2222-2222
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top